Drawing for OSTEOPLASMOLOGY

USPTO serial 79330197

OSTEOPLASMOLOGY

Reviewed by CopyMark Law Group

Reg. 6982552Status 700Registered
Filing date
Status date
Registration date
Feb 21, 2023
Examiner
KHAN, AHSEN M
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with OSTEOPLASMOLOGY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

CHRISTOPHER J. PALERMO

CHRISTOPHER J. PALERMO BAKER BOTTS, L.L.P.401 S 1ST STREETSUITE 1300AUSTIN, TX 78704

Goods and services

ClassDescriptionStatusFirst use
005Medical and veterinary preparations and articles, namely, platelet-rich plasma containing autologous proteins from human blood; Dental preparations and articles, namely, platelet-rich plasma containing autologous proteins from human blood; Pharmaceutical preparations used to treat dental conditions, namely, loss of bone in the maxillary sinus area due to tooth loss; Implantable materials for use in guided tissue regeneration in the nature of living tissue used as surgical implants, namely, a stable gel formulation of platelet-rich plasma containing autologous proteins from human blood; Implants comprising living issue for guided tissue regeneration; Biological tissue implants; Pre-filled syringes for medical and dental purposes in the nature of living tissue used as surgical implants, namely, a stable gel formulation of platelet-rich plasma containing autologous proteins from human blood; Structural parts and fittings for all the aforesaid goods, specifically, nozzles, sterile tubing, syringes and thumb tabs for plunging a plunger in a syringeACTIVE—
010Surgical, medical and dental apparatus and equipment, namely, nozzles and thumb tabs for plunging a plunger in a syringe; Nozzles being structural components of dental syringes; Injection needles for dental purposes; Structural parts and fittings for all the aforesaid goodsACTIVE—
044Facial treatment services, namely, maxillary sinus bone augmentation to allow for the replacement of missing teeth; Advisory services relating to the proper use of dental instruments, namely, advising on the correct technique and process in relation to maxillary sinus bone augmentationACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 12, 2023FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
May 23, 2023FICSFINAL DISPOSITION NOTICE SENT TO IB—
May 23, 2023FIMPFINAL DISPOSITION PROCESSED—
May 21, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Feb 21, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Feb 21, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 12, 2022GPNXNOTIFICATION PROCESSED BY IB—
Dec 6, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 6, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 23, 2022OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Nov 23, 2022OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Nov 16, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 31, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 29, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 28, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 28, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 20, 2022CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jul 20, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 20, 2022ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Jul 20, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 20, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 20, 2022COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jul 6, 2022RFNTREFUSAL PROCESSED BY IB—
Jun 15, 2022RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 15, 2022RFRRREFUSAL PROCESSED BY MPU—
May 14, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
May 13, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 12, 2022DOCKASSIGNED TO EXAMINER—
Jan 11, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Jan 7, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 6, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance